$CGEM

Cullinan Oncology Inc

  • NASDAQ
  • Other Consumer Services
  • Consumer Services

PRICE

$13.89 ▲3.425%

Delayed Price

VOLUME

16,285

DAY RANGE

- 13.915

52 WEEK

7.3 - 30.33

Join Discuss about CGEM with like-minded investors

profile
@CarlosH-carvan #ivtrades
recently

testing my gamma scan and results: $MASS, $POSH, $HRB, $STKL, $CRBU, $M, $EXPI, $CGEM, $DCON, $SQSP

146 Replies 9 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$CGEM on watch too

144 Replies 14 👍 6 🔥

Key Metrics

Market Cap

601.43 M

Beta

0

Avg. Volume

375.48 K

Shares Outstanding

44.78 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-09

Next Dividend Date

Company Information

Cullinan Management is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s strategy is to build a pipeline of therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes.

Website:

HQ: ,

Related News